Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.07.29.741441

Sleep complaints in alexithymia reflect non-specific negative affectivity

Abstract

Alexithymia is the inability to identify and describe emotions, associated with an increased risk of somatic and psychiatric disease. Alexithymia is also characterized by reduced subjective sleep quality. However, it is not well-known if this reduction in sleep quality reflects physiological changes in sleep, a specific alteration in perceived sleep quality not captured by objective metrics, or a non-specific spillover of the negative affective style which characterizes alexithymia. In BSETS, a large (N=228) EEG study of naturalistic sleep, we found that alexithymia symptoms are associated with worse habitual (AIS) and current (GSQS) subjective sleep quality ({beta}AIS=0.207, pAIS=0.002, {beta}GSQS=0.203, pGSQS=0.002). However, we observed no significant association between alexithymia and EEG-based sleep efficiency ({beta}=- 0.017, p=0.791). The association with subjective sleep quality was almost completely attenuated when controlling for either depressive symptoms (PHQ-9, {beta}AIS=0.001, pAIS=0.982, {beta}GSQS=0.044, pGSQS=0.486) or trait neuroticism (ZKPQ, BFI-44, {beta}AIS=0.057, pAIS=0.442, {beta}GSQS=0.048, pGSQS=0.514). A possible exception is the Difficulty Identifying Feelings alexithymia dimension, reflecting complaints about the labeling of interoceptive experiences, which was associated with lower subjective sleep quality even after covariate control. This pattern of findings suggests that alexithymia is characterized only by alterations of subjective sleep quality, and even these reflect a non-specific increase in negative affect which influences self-reports of sleep quality, rather than a specific reduction in perceived sleep quality itself.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ujma, P. P., Adibi, P.. 2026-08-04. Sleep complaints in alexithymia reflect non-specific negative affectivity. https://doi.org/10.64898/2026.07.29.741441

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Functional validation of allele-specific LMNB1 silencing in patient-derived astrocytes as a therapeutic option for Autosomal Dominant Leukodystrophy

Adult-onset Autosomal Dominant Leukodystrophy (ADLD) is a rare fatal leukodystrophy caused by increased LMNB1 gene dosage, most commonly resulting from duplication of the LMNB1 locus. Because ADLD is a gene dosage disorder, selective reduction of pathological LMNB1 expression represents a rational therapeutic strategy. Although allele-specific RNA interference has previously been shown to lower LMNB1 levels in patient-derived fibroblasts and directly reprogrammed neurons, its therapeutic effects have not been evaluated in disease-relevant human glial cells or using functional efficacy endpoints. Here, we established human induced pluripotent stem cell-derived astrocytes from ADLD patients as a human glial model in which to validate allele-specific LMNB1 silencing across molecular, cellular, and functional readouts. ADLD astrocytes recapitulated increased LMNB1 expression and characteristic nuclear abnormalities and displayed transcriptional alterations affecting extracellular matrix organization, calcium homeostasis, metabolism and RNA processing. Functionally, these cells also exhibited functional phenotypes suitable for therapeutic evaluation: astrocyte-conditioned medium impaired the viability of both murine and human oligodendroglial cultures, while conditioned-medium and direct astrocyte-seeding paradigms revealed impaired post-lesion myelin recovery in lysolecithin-treated cerebellar organotypic slices. Allele-specific LMNB1 silencing restored physiological LMNB1 levels, corrected nuclear abnormalities, attenuated astrocyte-mediated oligodendroglial toxicity, improved post-lesion myelin recovery, and was associated with selective transcriptional programs associated with extracellular support and cholesterol metabolism. Together, these findings provide molecular, cellular, and functional validation of allele-specific LMNB1 dosage correction in patient-derived human astrocytes and offer key support for LMNB1-lowering strategies in disease-relevant human glial cells.

neuroscience↗

Perceptual integration of multisensory haptic, visual, and auditory feedback for roughness discrimination in augmented reality

Understanding how our different senses interact to shape our perception is essential to design realistic and immersive virtual and augmented reality (VR/AR) experiences. The present study investigated how roughness perception can be modulated through haptic, visual, and auditory cues in AR using a vibrotactile wristband. Participants compared virtual textures varying in vibration frequency/amplitude, visual grain size, and friction sound. Results revealed strong linear relationships between stimulus parameters and perceived roughness, with haptic frequency and visual cues driving the highest discrimination performance. Adding non-informative sensory feedback reduced perceptual sensitivity, acting as noise. Individual differences emerged: participants who rated haptic as the easiest modality showed greater sensitivity to haptic variations, while visual-reliant participants performed better with visual cues. We conclude that roughness in AR can be systematically manipulated, but is vulnerable to perceptual interference from irrelevant inputs, where our work provides actionable insights for implementing optimized and adaptive AR/VR interfaces.

neuroscience↗

Structural and functional MRI signatures of Gambling Disorder: a case-control study

Gambling disorder (GD) is a behavioural addiction that may help identify addiction-related neural features without the direct neurobiological effects of a primary substance of dependence. We examined regional grey matter volume (GMV) and resting-state functional connectivity (rsFC) in the same well-characterised sample. Eighteen men with GD and 21 matched healthy controls underwent high-resolution structural and resting-state functional MRI. GMV was quantified across 214 cortical and subcortical regions, and seed-based rsFC analyses focused on striatal subdivisions and mesocorticolimbic regions. Group differences were evaluated using permutation testing and cluster-corrected mixed-effects modelling. GD was associated with lower GMV in the ventromedial prefrontal cortex, orbitofrontal regions and other cortical and subcortical areas, alongside higher GMV in a subset of limbic and default-mode regions. Participants with GD also showed lower connectivity between the limbic striatum and the hippocampus, thalamus and putamen. In exploratory analyses, somatomotor connectivity was positively associated with gambling severity (Problem Gambling Severity Index: Spearman's rho = 0.71, p = 0.003, false-discovery-rate-adjusted q = 0.016). Structural and functional findings overlapped spatially in regions associated with valuation, memory, reward and habit formation, but regional GMV did not mediate group differences in rsFC. These findings are broadly consistent with corticostriatal models of GD and identify candidate circuit-level differences for independent replication. Larger, more diverse and longitudinal samples are required to establish their reproducibility, temporal direction and clinical relevance.

neuroscience↗